Robert Sałat

Prof. Dr. Robert Sałat

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2004 in IEEE Transactions on Power Systems
Verified
Journal Article
Closed access
RSRobert Sałat
Robert Sałat
SOStanislaw Osowski
Stanislaw Osowski
The paper presents a new approach to the location of fault in the high-voltage power transmission line, relying on the application of the support vector machine and frequency characteristics of the measured one-terminal voltage and current transient signals of the system. The extensive numerical experiments performed for location of different kinds of faults of the transmission line have proved very good accuracy of fault location algorithm. The average error of fault location in a 200-km transmission line is below 100 m and the maximum error did not exceed 2 km.

1 July 2014 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
KSKinga Sałat
Kinga Sałat
ACAgnieszka Cios
Agnieszka Cios
Elżbieta WyskaElżbieta Wyska
Elżbieta Wyska
RSRobert Sałat
Robert Sałat
SMSzczepan Mogilski
Szczepan Mogilski
BMBarbara Malawska
Barbara Malawska

1 December 2015 in Pharmacological Reports
Verified
Journal Article
Closed access
KSKinga Sałat
Kinga Sałat
APAdrian Podkowa
Adrian Podkowa
SMSzczepan Mogilski
Szczepan Mogilski
PZPaula Zaręba
Paula Zaręba
KKKatarzyna Kulig
Katarzyna Kulig
BFBarbara Filipek
Barbara Filipek

25 October 2017 in Inflammopharmacology
Verified
Journal Article
Open access
PDF file
KSKinga Sałat
Kinga Sałat
AFAnna Furgała
Anna Furgała
RSRobert Sałat
Robert Sałat
Cebranopadol (a.k.a. GRT-6005) is a dually acting nociceptin/orphanin FQ and opioid receptor agonist that has been recently developed in Phase 2 clinical trials for painful diabetic neuropathy or cancer pain. It also showed analgesic properties in various rat models of pain and had a better safety profile as compared to equi-analgesic doses of morphine. Since antinociceptive properties of cebranopadol have been studied mainly in rat models, in the present study, we assessed analgesic activity of subcutaneous cebranopadol (10 mg/kg) in various mouse pain models.


1 October 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
AFAnna Furgała
Anna Furgała
ŁFŁukasz Fijałkowski
Łukasz Fijałkowski
Alicja NowaczykAlicja Nowaczyk
Alicja Nowaczyk
RSRobert Sałat
Robert Sałat
KSKinga Sałat
Kinga Sałat